Co-Diagnostics anticipates filing FDA 510(k) in the third quarter as CoSara expands TAM to approximately $13B
Co-Diagnostics, Inc. Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $6.20
+459% in 7d after detection
Post-detection moves
1h
—
1d
-21%
3d
+21%
7d
+459%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS